Literature DB >> 19231019

Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.

Bruno Roche, Didier Samuel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231019     DOI: 10.1016/j.jhep.2009.01.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Antiviral therapy in HCV-infected decompensated cirrhotics.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahmed E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

2.  Strategies to reduce hepatitis C virus recurrence after liver transplantation.

Authors:  Ruben Ciria; María Pleguezuelo; Shirin Elizabeth Khorsandi; Diego Davila; Abid Suddle; Hector Vilca-Melendez; Sebastian Rufian; Manuel de la Mata; Javier Briceño; Pedro López Cillero; Nigel Heaton
Journal:  World J Hepatol       Date:  2013-05-27

Review 3.  Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

Authors:  Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.

Authors:  Giuliano Ramadori; Patrizia Bosio; Federico Moriconi; Ihtzaz A Malik
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

5.  New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis.

Authors:  Deborah Lim Chua; Thomas Hahambis; Samuel H Sigal
Journal:  Hepat Med       Date:  2014-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.